In May 2018, the Lipusu Patient Assistance Program initiated by Luye Pharma and Beijing Kangmeng Charity Foundation, was launched in Xi'an, China. The program helps cancer patients by offering them the opportunity to receive timely, standardized and effective treatment, reducing patients’ financial burden, lower mortality rate and improve quality of life. The program has since benefited approximately 2000 patients with a total drug value of around RMB 30 million contributed by the company.
Lipusu Patient Assistance Program